Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Trio-Tech International (NY: TRT)
3.341 USD  -0.116 (-3.37%)
Official Closing Price  /  Updated: 8:00 PM EST, Nov 12, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,600
Open 3.508
Bid (Size) 3.260 (1)
Ask (Size) 3.950 (1)
Prev. Close 3.458
Today's Range 3.250 - 3.580
52wk Range 2.460 - 4.300
Shares Outstanding 3,553,055
Dividend Yield N/A
Performance
YTD
+30.01%
+30.01%
1 Month
-4.81%
-4.81%
3 Month
+4.41%
+4.41%
6 Month
+8.83%
+8.83%
1 Year
-20.45%
-20.45%
Top News
More News
Aytu BioScience’s (NasdaqCM: AYTU), Natesto®, May Emerge As The Best-In-Class Testosterone Replacement (TRT) Drug – (Video Report)
category Business , Pharmaceuticals & Biotech , Financial Market , and 2 more.
from AB Newswire
Is Aytu BioScience’s (NasdaqCM: AYTU) Natesto® About To Upend The Testosterone (TRT) Drug Market?
category Personal Finance , Financial Market , Health & Medicine , and 2 more.
from AB Newswire
More News
Read More
Report: Exploring Fundamental Drivers Behind CSW Industrials, DMC Global, National HealthCare, Milestone Scientific, EnSync, and Trio-Tech International — New Horizons, Emerging Trends, and Upcoming D
from GlobeNewswire News Releases
Trio-Tech Reports Fourth Quarter and Fiscal 2019 Results
from Business Wire News Releases
Trio-Tech Third Quarter Net Income is $0.19 Per Share Versus Loss
from Business Wire News Releases
Trio-Tech Second Quarter Net Income $0.09 Per Diluted Share
from Business Wire News Releases
Trio-Tech Reports First Quarter Fiscal 2019 Results
from Business Wire News Releases
Trio-Tech Fourth Quarter Net Income Increased 91% to $0.17 Per Diluted Share Versus $0.09 Per Share Last Year
from Business Wire News Releases
Trio-Tech Reports Third Quarter and Nine Months Results
from Business Wire News Releases
Trio-Tech Fiscal 2018 Second Quarter Net Income Doubles to $0.18 Per Share As Revenue Increases 16%
from Business Wire News Releases
Cramer's lightning round: The case for buying the best-of-breed stock of UnitedHealth
category Markets , Stock markets , Personal investing , and 16 more.
from CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.